Long COVID in a prospective cohort of home-isolated patients

  title={Long COVID in a prospective cohort of home-isolated patients},
  author={Bj{\o}rn Blomberg and Kristin Greve-Isdahl Mohn and Karl Albert Brokstad and Fan Zhou and Dagrunn Waag Linchausen and Bent-Are Hansen and Sarah Lartey and Therese Bredholt Onyango and Kanika Kuwelker and Marianne S{\ae}vik and Hauke Bartsch and Camilla T{\o}ndel and Bård Reiakvam Kittang and Rebecca Jane Cox and Nina Langeland},
  journal={Nature Medicine},
  pages={1607 - 1613}
Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients—247 home-isolated and 65 hospitalized—comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of… 
Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study
Persisting symptoms are common after COVID-19 especially in hospitalized patients compared to outpatients, and special attention and clinical follow-up after acute SARS-CoV-2 infection should be provided for hospitalized patients with previous lung diseases, tobacco consumption, and women.
Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort
The disease impact on patients’ lives began increasing 6 months after onset, and evolution of symptoms showed a decreasing prevalence over time for 27/53 symptoms, and an increasing prevalenceover time for 8/ 53 symptoms.
Clinical Characteristics of Japanese Patients Who Visited a COVID-19 Aftercare Clinic for Post-Acute Sequelae of COVID-19/Long COVID
Regardless of the severity in the acute phase, patients visiting the CAC clinic suffered from a variety of symptoms, and neurological, psychiatric, and extremity symptoms were predominant one month after the onset of COVID-19.
Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months’ follow-up
Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Children in the control group experienced significantly more concentration difficulties, headache, muscle and joint pain, cough, nausea, diarrhea and fever than SARS-CoV-2 infected, and in most children ‘long COVID’ symptoms resolved within 1–5 months.
Post COVID-19 Condition in Children and Adolescents: An Emerging Problem
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection became a pandemic in 2020 and by March 2022 had caused more than 479 million infections and 6 million deaths worldwide.
Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
Male sex, age younger than 35 years, and low COVID-19 exposures were associated with better recovery and return to usual health, and an active medical follow-up of post-CO VID-19 patients must be implemented.
Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study
Age had an inverted-U formed association with a worsening of health while being fit and being a health professional were associated with lower multivariate odds, and neither gender nor follow-up time was associated with the multivariate Odds of worsening of self-reported health compared to one year ago.


Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation
Survivors of COVID-19 exhibit a complex array of symptoms, whose common underlying pathology, if any, has still to be elucidated: a multidisciplinary approach is fundamental to address the different problems and to look for effective solutions.
Remdesivir for the Treatment of Covid-19 — Final Report
The data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.
Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It?
It is suggested that the phenomenon of Long-COVID may not be directly attributable to the effect of SARS-CoV-2, and believe the biopsychosocial effects of COVID-19 may play a greater role in its aetiology.
Post-infectious fatigue syndrome in dengue infection.
  • R. Seet, A. Quek, E. Lim
  • Medicine
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
  • 2007
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Most convalescent plasma samples obtained from individuals who recover from COVID-19 do not contain high levels of neutralizing activity, and rare but recurring RBD-specific antibodies with potent antiviral activity were found in all individuals tested, suggesting that a vaccine designed to elicit such antibodies could be broadly effective.
SARS-CoV-2–Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study
The data show a low number of SARS-CoV-2–seropositive HCW in a low-prevalence setting; however, the proportion of seropositivity was higher than RT-PCR positivity, highlighting the importance of antibody testing.